Company Overview

Krishna Institute of Medical Sciences (KIMS) is one of South India's largest corporate hospital chains, headquartered in Secunderabad, Telangana. Founded by Dr. Bhaskar Rao in 2000, the company operates a network of multi-specialty hospitals primarily across Telangana, Andhra Pradesh, and Maharashtra.

KIMS is known for its focus on Tier-2 and Tier-3 cities — a differentiated strategy compared to peers like Apollo and Max Healthcare who are concentrated in metros. The company went public in June 2021 with a highly successful IPO that was subscribed over 4 times.

Recent Developments & News

Q4 FY26 Results

KIMS reported its Q4 FY26 results in late April 2026. Key highlights:

• Revenue: ₹580 crore, up 18% YoY — driven by increased patient volumes and higher ARPOB (Average Revenue Per Occupied Bed)
• EBITDA Margin: 24.5%, stable QoQ but down 120 bps YoY due to higher doctor compensation and medical equipment costs
• Net Profit: ₹85 crore, up 14% YoY
• Occupancy Rate: 72% across the network, up from 68% in Q4 FY25
• ARPOB: ₹42,500 per day, up 8% YoY

New Hospital Openings

KIMS inaugurated two new hospitals in FY26:

• KIMS Kurnool: 300-bed multi-specialty hospital opened in December 2025
• KIMS Nagpur: 200-bed facility opened in March 2026, marking KIMS' entry into Maharashtra beyond its existing presence

Management Commentary

Financial Snapshot

KIMS maintains a strong balance sheet with minimal debt relative to equity. The company has been funding expansion primarily through internal accruals and a small portion of debt, avoiding the aggressive leverage that has hurt some hospital chains in the past.

Expansion Strategy

KIMS has laid out a clear growth roadmap:

• Bed Expansion: From 4,000 beds currently to 6,000 beds by FY28 and 8,000 beds by FY30
• Geographic Diversification: Entering Karnataka (Bangalore, Mysore) and Tamil Nadu (Chennai, Coimbatore) over the next 2 years
• Greenfield vs Brownfield: 60% of new capacity through greenfield projects; 40% through acquisitions of distressed or underperforming hospitals
• Specialty Focus: Increasing share of high-margin specialties — cardiac sciences, oncology, and organ transplants
• Digital Health: Launching telemedicine and home healthcare services under the "KIMS Care" brand

Industry Position

KIMS operates in India's rapidly growing healthcare sector, which is expected to reach $638 billion by 2030 (from ~$370 billion in 2025). Key competitive dynamics:

• vs Apollo Hospitals: Apollo is 3x larger by revenue but concentrated in metros. KIMS wins on cost efficiency and regional dominance.
• vs Max Healthcare: Max is North India focused and premium-priced. KIMS targets the mass-affluent segment in South/Central India.
• vs Narayana Health: Both focus on affordability, but KIMS has a stronger presence in Andhra/Telangana.
• vs Regional Players: KIMS' corporate governance and scale give it an edge over fragmented regional hospitals.